Results 11 to 20 of about 1,337,415 (292)

Understanding and targeting resistance mechanisms in cancer

open access: yesMedComm, 2023
Resistance to cancer therapies has been a commonly observed phenomenon in clinical practice, which is one of the major causes of treatment failure and poor patient survival. The reduced responsiveness of cancer cells is a multifaceted phenomenon that can
Zi‐Ning Lei   +6 more
doaj   +1 more source

Nanoparticles for Combination Drug Therapy [PDF]

open access: yesACS Nano, 2013
Nanoparticles have recently emerged as a promising class of carriers for the co-delivery of multiple drugs. Combination therapies of small-molecule drugs are common in clinical practice, and it is anticipated that packaging into single macromolecular carriers will enable drug release in precisely balanced ratios and rates and in selectively targeted ...
Liang Ma, Andrew M. Smith, Manish Kohli
openaire   +3 more sources

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently needed.
Talia Greenstein   +5 more
doaj   +1 more source

Drug Combinations in Breast Cancer Therapy [PDF]

open access: yesPharmaceutical Nanotechnology, 2019
Breast cancer therapy involves a multidisciplinary approach comprising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with minimal undesirable effects to ensure a good quality of life for patients.
Funmilola A. Fisusi, Emmanuel O. Akala
openaire   +3 more sources

Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapy [PDF]

open access: yes, 2014
The receptor tyrosine kinases (RTKs) are key drivers of cancer progression and targets for drug therapy. A major challenge in anti-RTK treatment is the dependence of drug effectiveness on co-expression of multiple RTKs which defines resistance to single ...
Bown, James L.   +8 more
core   +6 more sources

Prescribing pattern of antipsychotic drugs in the outpatient department of psychiatry in Silchar Medical College and Hospital, Assam

open access: yesOpen Journal of Psychiatry and Allied Sciences, 2016
Objective: To study the prescribing pattern of antipsychotic drugs in the outpatient department of psychiatry in Silchar Medical College and Hospital (SMCH) of Assam.
Pinaki Chakravarty   +2 more
doaj   +1 more source

Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy

open access: yesJournal of Functional Biomaterials, 2023
Standard cancer chemotherapeutics often produce significant adverse effects and eventually lose their effectiveness due to the emergence of resistance mechanisms.
Amir R. Afshari   +3 more
doaj   +1 more source

Machine learning approaches for drug combination therapies [PDF]

open access: yesBriefings in Bioinformatics, 2021
AbstractDrug combination therapy is a promising strategy to treat complex diseases such as cancer and infectious diseases. However, current knowledge of drug combination therapies, especially in cancer patients, is limited because of adverse drug effects, toxicity and cell line heterogeneity. Screening new drug combinations requires substantial efforts
Betul Guvenc Paltun   +7 more
openaire   +4 more sources

The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study

open access: yesBMC Urology, 2021
Background Combination drug therapy for lower urinary tract symptoms (LUTS) is beneficial to selected patients and recommended by guidelines. Patterns of real-world LUTS drug use, especially combination drug therapy, have not been studied extensively ...
Mahmood Ali   +6 more
doaj   +1 more source

Two-year follow-up of macaques developing intermittent control of the human immunodeficiency virus homolog simian immunodeficiency virus SIVmac251 in the chronic phase of infection [PDF]

open access: yes, 2015
Off-therapy control of viremia by HIV-infected individuals has been associated with two likely players: a restricted viral reservoir and an efficient cell-mediated immune response.
Arts, Eric   +14 more
core   +2 more sources

Home - About - Disclaimer - Privacy